The purpose of this study is to determine whether NEA TDS is effective in the prevention of pregnancy. The safety of this product will also be evaluated.
An Open Label Study to Evaluate the Contraceptive Efficacy and Safety of Norethindrone Acetate Transdermal Delivery System.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
1,659
Norethindrone Acetate Transdermal Delivery System
Pregnancy Rate
The pregnancy rate will be calculated using the Pearl Index that defined as 1300\*Number of pregnancies/Number of cycles of treatment.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Watson Investigational Site
Birmingham, Alabama, United States
Watson Investigational Site
Mobile, Alabama, United States
Watson Investigational Site
Montgomery, Alabama, United States
Watson Investigational Site
Chandler, Arizona, United States
Watson Investigational Site
Little Rock, Arkansas, United States
Watson Investigational Site
Garden Grove, California, United States
Watson Investigational Site
La Mesa, California, United States
Watson Investigational Site
San Diego, California, United States
Watson Investigational Site
Denver, Colorado, United States
Watson Investigational Site
Newark, Delaware, United States
...and 43 more locations